Literature DB >> 19619416

The physiologic responses of Dutch belted rabbits infected with inhalational anthrax.

William S Lawrence1, Jason M Hardcastle, Douglas L Brining, Lori E Weaver, Cindy Ponce, Elbert B Whorton, Johnny W Peterson.   

Abstract

Bacillus anthracis, the causative agent of anthrax, is a category A priority pathogen that causes extensive damage in humans. For this reason, B. anthracis has been the focus of numerous studies using various animal models. In this study, we explored physiologic parameters in Dutch belted rabbits with inhalation anthrax to characterize the disease progression in this model. To this end, we infected Dutch belted rabbits with 100 LD(50) B. anthracis Ames spores by nasal instillation and continuously recorded various physiologic parameters by using telemetry. In addition, samples were collected at selected times for serum chemistry, hematology, and blood gas analysis. The animals exhibited hemodynamic and respiratory changes that coincided with those reported in human cases of inhalational anthrax infection, including hypotension, altered heart rate, and respiratory distress. Likewise, hematology, serum chemistry, and blood gas analysis revealed trends comparable to human anthrax-related pathophysiology. The Dutch belted rabbit model of inhalational anthrax exhibited most of the physiologic, hematologic, and biochemical sequelae noted in human cases. Therefore, this rabbit model fulfills several of the criteria of a useful animal model for studying disease pathogenesis and evaluating therapeutics during inhalational anthrax.

Entities:  

Mesh:

Year:  2009        PMID: 19619416      PMCID: PMC2733296     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  48 in total

Review 1.  Inhalational anthrax.

Authors:  Aletta Ann Frazier; Teri J Franks; Jeffrey R Galvin
Journal:  J Thorac Imaging       Date:  2006-11       Impact factor: 3.000

Review 2.  Contribution of toxins to the pathogenesis of inhalational anthrax.

Authors:  Jean-Nicolas Tournier; Anne Quesnel-Hellmann; Aurélie Cleret; Dominique R Vidal
Journal:  Cell Microbiol       Date:  2007-01-11       Impact factor: 3.715

3.  Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits.

Authors:  Shay Weiss; David Kobiler; Haim Levy; Hadar Marcus; Avi Pass; Nili Rothschild; Zeev Altboum
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.

Authors:  S F Little; B E Ivins; W M Webster; P F Fellows; M L M Pitt; S L W Norris; G P Andrews
Journal:  Vaccine       Date:  2005-12-27       Impact factor: 3.641

5.  Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice.

Authors:  Aaron M Firoved; Georgina F Miller; Mahtab Moayeri; Rahul Kakkar; Yuequan Shen; Jason F Wiggins; Elizabeth M McNally; Wei-Jen Tang; Stephen H Leppla
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

6.  Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains.

Authors:  Melissa Drysdale; Gwyneth Olson; Theresa M Koehler; Mary F Lipscomb; C Rick Lyons
Journal:  Infect Immun       Date:  2007-01-22       Impact factor: 3.441

7.  Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis.

Authors:  Ian Justin Glomski; Jean-Philippe Corre; Michèle Mock; Pierre Louis Goossens
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 8.  Anthrax toxins: A paradigm of bacterial immune suppression.

Authors:  Cosima T Baldari; Fiorella Tonello; Silvia Rossi Paccani; Cesare Montecucco
Journal:  Trends Immunol       Date:  2006-07-24       Impact factor: 16.687

9.  Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model.

Authors:  Xizhong Cui; Yan Li; Xuemei Li; Michael W Laird; Mani Subramanian; Mahtab Moayeri; Stephen H Leppla; Yvonne Fitz; Junwu Su; Kevin Sherer; Peter Q Eichacker
Journal:  J Infect Dis       Date:  2007-01-03       Impact factor: 5.226

10.  Lethal and edema toxins of anthrax induce distinct hemodynamic dysfunction.

Authors:  Linley E Watson; Jonathan Mock; Hind Lal; Guangrong Lu; Raymond W Bourdeau; Wei-Jen Tang; Stephen H Leppla; David E Dostal; Arthur E Frankel
Journal:  Front Biosci       Date:  2007-05-01
View more
  13 in total

1.  Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague.

Authors:  Christina J van Lier; Jian Sha; Michelle L Kirtley; Anthony Cao; Bethany L Tiner; Tatiana E Erova; Yingzi Cong; Elena V Kozlova; Vsevolod L Popov; Wallace B Baze; Ashok K Chopra
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

2.  Using Telemetry Data to Refine Endpoints for New Zealand White Rabbits Challenged with Bacillus anthracis.

Authors:  David G Dawson; Kristin A Bower; Candace N Burnette; Rebecca K Holt; James R Swearengen; Paul A Dabisch; Angelo Scorpio
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-11-01       Impact factor: 1.232

3.  Toll-like receptor 4 knockout protects against anthrax lethal toxin-induced cardiac contractile dysfunction: role of autophagy.

Authors:  Machender R Kandadi; Arthur E Frankel; Jun Ren
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

4.  Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.

Authors:  Steven B Yee; Joshua M Hatkin; David N Dyer; Steven A Orr; M Louise M Pitt
Journal:  Comp Med       Date:  2010-12       Impact factor: 0.982

5.  Pathology and pathophysiology of inhalational anthrax in a guinea pig model.

Authors:  Vladimir Savransky; Daniel C Sanford; Emily Syar; Jamie L Austin; Kevin P Tordoff; Michael S Anderson; Gregory V Stark; Roy E Barnewall; Crystal M Briscoe; Laurence Lemiale-Biérinx; Sukjoon Park; Boris Ionin; Mario H Skiadopoulos
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

6.  Targeted silencing of anthrax toxin receptors protects against anthrax toxins.

Authors:  Maria T Arévalo; Ashley Navarro; Chenoa D Arico; Junwei Li; Omar Alkhatib; Shan Chen; Diana Diaz-Arévalo; Mingtao Zeng
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

7.  Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment.

Authors:  Jason E Comer; Bryan D Ray; Lisa N Henning; Gregory V Stark; Roy E Barnewall; Jason M Mott; Gabriel T Meister
Journal:  Clin Vaccine Immunol       Date:  2012-07-25

8.  Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits.

Authors:  Steven B Yee; David N Dyer; Nancy A Twenhafel; M Louise M Pitt
Journal:  Comp Med       Date:  2013-06       Impact factor: 0.982

9.  Cardiac-specific catalase overexpression rescues anthrax lethal toxin-induced cardiac contractile dysfunction: role of oxidative stress and autophagy.

Authors:  Machender R Kandadi; Xuejun Yu; Arthur E Frankel; Jun Ren
Journal:  BMC Med       Date:  2012-11-07       Impact factor: 8.775

10.  Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia.

Authors:  Bradford W Gutting; Tonya L Nichols; Stephen R Channel; Jeffery M Gearhart; George A Andrews; Alan E Berger; Ryan S Mackie; Brent J Watson; Sarah C Taft; Katie A Overheim; Robert L Sherwood
Journal:  Front Cell Infect Microbiol       Date:  2012-06-28       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.